Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden.

Authors:
Henry N; Hawes C; Lowin J; Lekander I; Filonenko A and 1 more

Journal:
Acta Obstet Gynecol Scand

Publication Year: 2015

DOI:
10.1111/aogs.12679

PMCID:
PMC4744785

PMID:
26015090

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Obstet Gynecol Scand

Abbreviation: Acta Obstet Gynecol Scand

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gynecology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Birth asphyxia and its association with grand multiparity and referral among hospital births: A pro…
Handing G; Straneo M; Agossou C and 5 more (2024) - Transparency Score: 3/6
Accuracy and precision of sonographic fetal weight estimation in Sweden.
Lindström L; Cnattingius S; Axelsson O and 1 more (2023) - Transparency Score: 3/6
Accuracy of colposcopy in the Swedish screening program.
Alfonzo E; Zhang C; Daneshpip F and 1 more (2023) - Transparency Score: 3/6
A cervical screening initiative for elderly women in Denmark.
Skorstengaard M; Viborg PH; Telén Andersen AB and 10 more (2023) - Transparency Score: 3/6
Adrenal volumes in fetuses delivering prior to 32 weeks' gestation: An MRI pilot study.
Hall M; Hutter J; Uus A and 11 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"NH and JL are full‐time employees of IMS Health who served as paid consultants to Bayer Pharma AG during the development of this study and manuscript. CH was a full‐time employee of IMS Health during the development of this study and manuscript. IL was a full‐time employee of Bayer AB during the development of this study and manuscript. AF is a full‐time employee of Bayer Pharma AG. HKK has received honoraria for consultancy work performed for Bayer Pharma AG but has received no compensation for participating in the writing of this manuscript."

Evidence found in paper:

"Funding This study was funded by Bayer Pharma AG."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025